EUVIMEDEUVIMED entdecken
Crossref

Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer

Rui Wu, Georgia Zachou, Agnieszka Michael

Academia Oncology · 27.03.2026 · 3 (1)

DOI: 10.20935/acadonco8189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academia Oncology, online erschienen am 27.03.2026. Verfasst von Rui Wu und 2 weiteren Autor:innen. Die Arbeit nennt 124 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction: Ovarian cancer is a leading cause of gynaecological cancer mortality. Ca125, the most widely used serum biomarker, has limited sensitivity for early-stage and type I tumours, prompting evaluation of additional blood-based markers. This umbrella review assesses the diagnostic and prognostic performance of serum and blood biomarkers in ovarian cancer.

Zitieren

APA

Wu, R., Zachou, G., & Michael, A. (2026). Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer. Academia Oncology, 3(1). https://doi.org/10.20935/acadonco8189

Vancouver

Wu R, Zachou G, Michael A. Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer. Academia Oncology. 2026;3(1). doi:10.20935/acadonco8189

BibTeX
@article{Wu2026,
  author = {Wu, Rui and Zachou, Georgia and Michael, Agnieszka},
  title = {Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer},
  journal = {Academia Oncology},
  year = {2026},
  volume = {3},
  number = {1},
  doi = {10.20935/acadonco8189}
}
Kostenlos starten →